- Supported exchanges /
- F /
- 9H4.F
LUNGLIFE AI INC. DL-0001 (9H4 F) stock market data APIs
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.
LUNGLIFE AI INC. DL-0001 Financial Data Overview
| 0.098 | |
| 0.099 | |
| - | |
| 0.099 | |
| 0.098 | |
| 0.093-1 | |
| 3 115 K | |
| 30 659 K | |
| 29 000 | |
| -0.303 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
LUNGLIFE AI INC. DL-0001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 29 000
- EBITDA -4 362 000
- Earnings Per Share -0.15
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get LUNGLIFE AI INC. DL-0001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get LUNGLIFE AI INC. DL-0001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
